Peanuts for Cardiometabolic, Brain, and Intestinal Health
Launched by GEORGIA STATE UNIVERSITY · Mar 4, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether eating peanuts and peanut products every day can help improve health in people with prediabetes. Prediabetes means that blood sugar levels are higher than normal but not high enough for a diabetes diagnosis. The study will last for 13 months and will include a diverse group of participants to see if peanuts can positively affect heart health, brain function, and gut health.
To participate, individuals need to be between 20 and 59 years old and have prediabetes, which is defined as having fasting blood sugar levels between 100-125 mg/dL or a specific test result (HbA1c) between 5.7-6.4%. However, people with peanut allergies, certain medical conditions, or those taking specific medications will not be eligible to join. Participants can expect to incorporate peanuts into their daily diet and track their health over the study period. This trial is currently recruiting participants, and it's a great opportunity for those looking to improve their health through diet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • men and women
- • 20-59 years of age
- • Prediabetes (fasting blood glucose levels 100-125 mg/dL and/or HbA1c between 5.7-6.4%)
- Exclusion Criteria:
- • Allergies to peanuts and peanut products
- • Use of insulin, antidiabetic, antibiotics, and anti-inflammatory drugs
- • Active cancer, gastrointestinal, renal, cardiovascular, thyroid, and neurological diseases or severe head injury
- • Smoking
- • Consumes greater than 2 alcoholic beverages per day
- • Consumes antioxidant, probiotic, and prebiotic supplements
- • Pregnant or Lactating
- • Actively participating in a weight loss program
About Georgia State University
Georgia State University is a leading research institution dedicated to advancing knowledge through innovative clinical trials and studies. With a strong emphasis on public health and community well-being, the university leverages its multidisciplinary expertise to conduct rigorous research aimed at addressing pressing health challenges. As a sponsor of clinical trials, Georgia State University fosters collaboration among researchers, healthcare professionals, and community partners, ensuring ethical standards and scientific integrity are upheld throughout the research process. Its commitment to translating research findings into real-world applications positions the university as a key contributor to the advancement of medical science and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Rafaela G Feresin, PhD
Principal Investigator
Georgia State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported